| Quiescin sulfhydryl oxidase 1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by driving EGFR endosomal trafficking and inhibiting NRF2 activation J Sun, C Zhou, Y Zhao, X Zhang, W Chen, Q Zhou, B Hu, D Gao, L Raatz, ... Redox biology 41, 101942, 2021 | 138 | 2021 |
| Tumor associated macrophages-derived exosomes facilitate hepatocellular carcinoma malignance by transferring lncMMPA to tumor cells and activating glycolysis pathway M Xu, C Zhou, J Weng, Z Chen, Q Zhou, J Gao, G Shi, A Ke, N Ren, H Sun, ... Journal of Experimental & Clinical Cancer Research 41 (1), 253, 2022 | 90 | 2022 |
| SLFN11 inhibits hepatocellular carcinoma tumorigenesis and metastasis by targeting RPS4X via mTOR pathway C Zhou, C Liu, W Liu, W Chen, Y Yin, CW Li, JL Hsu, J Sun, Q Zhou, H Li, ... Theranostics 10 (10), 4627, 2020 | 84 | 2020 |
| Disruption of SLFN11 Deficiency–Induced CCL2 Signaling and Macrophage M2 Polarization Potentiates Anti–PD-1 Therapy Efficacy in Hepatocellular Carcinoma C Zhou, J Weng, C Liu, S Liu, Z Hu, X Xie, D Gao, Q Zhou, J Sun, R Xu, ... Gastroenterology 164 (7), 1261-1278, 2023 | 55 | 2023 |
| Integrated analysis of copy number variations and gene expression profiling in hepatocellular carcinoma C Zhou, W Zhang, W Chen, Y Yin, M Atyah, S Liu, L Guo, Y Shi, Q Ye, ... Scientific reports 7 (1), 10570, 2017 | 50 | 2017 |
| Silencing GTSE-1 expression inhibits proliferation and invasion of hepatocellular carcinoma cells L Guo, S Zhang, B Zhang, W Chen, X Li, W Zhang, C Zhou, J Zhang, ... Cell biology and toxicology 32, 263-274, 2016 | 50 | 2016 |
| GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism Q Zhou, Y Yin, M Yu, D Gao, J Sun, Z Yang, J Weng, W Chen, M Atyah, ... Redox biology 56, 102458, 2022 | 45 | 2022 |
| Liver stiffness assessed by shear wave elastography predicts postoperative liver failure in patients with hepatocellular carcinoma Y Shen, C Zhou, G Zhu, G Shi, X Zhu, C Huang, J Zhou, J Fan, H Ding, ... Journal of Gastrointestinal Surgery 21 (9), 1471-1479, 2017 | 45 | 2017 |
| PARG inhibition limits HCC progression and potentiates the efficacy of immune checkpoint therapy M Yu, Z Chen, Q Zhou, B Zhang, J Huang, L Jin, B Zhou, S Liu, J Yan, X Li, ... Journal of hepatology 77 (1), 140-151, 2022 | 39 | 2022 |
| High RPS3A expression correlates with low tumor immune cell infiltration and unfavorable prognosis in hepatocellular carcinoma patients C Zhou, J Weng, C Liu, Q Zhou, W Chen, JL Hsu, J Sun, M Atyah, Y Xu, ... American journal of cancer research 10 (9), 2768, 2020 | 39 | 2020 |
| High GCLC level in tumor tissues is associated with poor prognosis of hepatocellular carcinoma after curative resection J Sun, C Zhou, Q Ma, W Chen, M Atyah, Y Yin, P Fu, S Liu, B Hu, N Ren, ... Journal of Cancer 10 (15), 3333, 2019 | 39 | 2019 |
| A simulation-based vessel-truck coordination strategy for lighterage terminals C Zhou, H Li, BK Lee, Z Qiu Transportation Research Part C: Emerging Technologies 95, 149-164, 2018 | 36 | 2018 |
| New insight into BIRC3: A novel prognostic indicator and a potential therapeutic target for liver cancer PY Fu, B Hu, XL Ma, ZF Yang, MC Yu, HX Sun, A Huang, X Zhang, ... Journal of cellular biochemistry 120 (4), 6035-6045, 2019 | 34 | 2019 |
| Emerging technology and management research in the container terminals: Trends and the COVID-19 pandemic impacts C Zhou, S Zhu, MGH Bell, LH Lee, EP Chew Ocean & Coastal Management 230, 106318, 2022 | 31 | 2022 |
| Long non-coding RNA00364 represses hepatocellular carcinoma cell proliferation via modulating p-STAT3-IFIT2 signaling axis WG Tang, B Hu, HX Sun, QM Sun, C Sun, PY Fu, ZF Yang, X Zhang, ... Oncotarget 8 (60), 102006, 2017 | 31 | 2017 |
| Information-based allocation strategy for grid-based transshipment automated container terminal C Zhou, EP Chew, LH Lee Transportation Science 52 (3), 707-721, 2018 | 26 | 2018 |
| Green port oriented resilience improvement for traffic-power coupled networks L Zhen, S Lin, C Zhou Reliability Engineering & System Safety 225, 108569, 2022 | 25 | 2022 |
| Ribonuclease 7-driven activation of ROS1 is a potential therapeutic target in hepatocellular carcinoma C Liu, Z Zha, C Zhou, Y Chen, W Xia, YN Wang, HH Lee, Y Yin, M Yan, ... Journal of hepatology 74 (4), 907-918, 2021 | 25 | 2021 |
| Intratumoral PPT1-positive macrophages determine immunosuppressive contexture and immunotherapy response in hepatocellular carcinoma J Weng, S Liu, Q Zhou, W Xu, M Xu, D Gao, Y Shen, Y Yi, Y Shi, Q Dong, ... Journal for immunotherapy of cancer 11 (6), e006655, 2023 | 21 | 2023 |
| High RPS11 level in hepatocellular carcinoma associates with poor prognosis after curative resection C Zhou, J Sun, Z Zheng, J Weng, M Atyah, Q Zhou, W Chen, Y Zhang, ... Annals of Translational Medicine 8 (7), 466, 2020 | 21 | 2020 |